Elsevier Acquires Laboratory Data Management Tool Hivebench

AMSTERDAM, June 7, 2016 /PRNewswire/ --

Integration With Elsevier's Research Data Management Portfolio Helps Researchers Prepare, Conduct and Analyze Experiments, Methods, and Protocols in One Place, Saving Them Valuable Time 

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today the acquisition of Hivebench, the flagship product of researcher application developer Shazino, based in Lyon, France. This tool will be integrated into Elsevier's existing Research Data Management portfolio, resulting in the further enhancement of the researcher experience.  

Hivebench is a digital laboratory notebook that helps researchers prepare, conduct and analyze experiments, methods, and protocols in one place, saving them valuable time. Hivebench has thousands of registered users, mostly biological laboratory researchers, and is positioned in the center of the research process. Hivebench is the only electronic laboratory notebook available on the web, on desktop (OSX) and mobile (iOS) devices.

"Linking the tool with the Elsevier tools and Mendeley Data repositories will improve the overall experience and quality of data normalization, without requiring the researcher to do any extra work," says Wouter Haak, Vice President Research Data Management at Elsevier. "Additional metadata and actions from the researcher will be captured via daily micro-steps instead of the current process of having to structure, manage and submit data all the way at the point of submission. The integration of Hivebench is an essential next step in further developing our integrated portfolio of research data management tools that truly make a difference in the way researchers do their job."

"We've been collaborating with Elsevier's Mendeley for the past two years and already enable Hivebench users to export their results to Mendeley Data," said Julien Thérier, CEO and founder of Shazino and Hivebench. "Being part of the Elsevier's Research Data Management portfolio will allow us to reach more researchers and install Hivebench locally in laboratories and organizations."

The acquisition will also benefit institutions and funders. The integration of Hivebench with Elsevier's 'funder compliance check' module, that will be developed in 2016 for the Elsevier and Mendeley data repositories, will also ensure that the data complies with funder requirements. Both institutions and funders are seeking this link between the data in the laboratory and the data posting requirements. With the Hivebench acquisition, this link is just a mouse click away. Julien Thérier and Vincent Tourraine (lead developer at Hivebench) will join Elsevier's Mendeley Data team in London.

Research data is the foundation on which scientific, technical and medical knowledge is built, but there are challenges in making it accessible and shareable. Elsevier is addressing these challenges by creating solutions that support researchers to store, share, discover and use data. That way, authors receive credit for their work while the wider research community benefits from discovering and using research data. Some of Elsevier's existing initiatives enable: posting data in repositories, supplementary data depositing, data journals and promotion of the use of proper data citation practices as laid out in the Joint Declaration of Data Citation Principles which Elsevier has endorsed.

The acquisition is effective immediately and financial terms of the transaction are not being disclosed. More information and updates on this news can be found on Elsevier Connect, Elsevier's online community, and on the Mendeley blog.

About Elsevier: 

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey - and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. http://www.elsevier.com

Media contact
Harald Boersma
Director, Corporate Relations, Elsevier
+31 20 485 27 36
h.boersma@elsevier.com